<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Elgart</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cherniakov</surname>
    <given-names class="given-names">I.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Aldouby</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Domb</surname>
    <given-names class="given-names">A. J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hoffman</surname>
    <given-names class="given-names">A.</given-names>
   </name>
  </person-group> (
  <year class="year">2013</year>). 
  <article-title class="article-title">Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems. (SNEDDS): the underlying mechanisms for amiodarone and talinolol.</article-title>
  <source class="source">
   <italic class="italic">Pharm. Res.</italic>
  </source>
  <volume class="volume">30</volume>
  <fpage class="fpage">3029</fpage>â€“
  <lpage class="lpage">3044</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1007/s11095-013-1063-y</pub-id>
  <?supplied-pmid 23686373?>
  <pub-id pub-id-type="pmid" class="pub-id">23686373</pub-id>
 </mixed-citation>
</ref>
